Pfizer-BioNTech said its COVID-19 vaccine works in children ages 5-11 and it plans to seek emergency use authorization in the U.S. for the age group soon. 

The vaccine maker shared this Monday, which is positive news as Minnesota and the rest of the U.S. seek to get more young people vaccinated. The Pfizer vaccine has already been approved in those who are 12 and older. 

“Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine. We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the delta variant and the substantial threat it poses to children,” Albert Bourla, the chairman and chief executive officer at Pfizer, said. 

Related [Aug. 23]: FDA gives full approval to Pfizer's COVID-19 vaccine

Pfizer tested a lower dose of the two-dose vaccine in kids 5-11 (a third of what's given to people 12 and older), a news release said. 

“The safety profile and immunogenicity data in children aged 5 to 11 years vaccinated at a lower dose are consistent with those we have observed with our vaccine in other older populations at a higher dose,” Dr. Ugur Sahin, CEO and co-founder of BioNTech, said.

Although kids are at a lower risk of getting seriously ill from COVID-19, the number of cases among children has risen in recent months. From Aug. 26-Sept. 9, the number of child cases of COVID-19 increased by 10%, and the two-week period prior they're up 10%, the American Academy of Pediatrics (AAP) says.

As of Sept. 9, there have been more than 5.2 million child COVID-19 cases reported, with kids representing about 15.5% of all cases, AAP says. In Minnesota, there have been 126,081 cases among kids — three children between the ages of 0-19 have died (0.04% of all cases).

"Since July, pediatric cases of COVID-19 have risen by about 240% in the U.S. – underscoring the public health need for vaccination," Bourla added. "These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency.”

Pfizer said "topline" details about the effectiveness of the COVID-19 vaccine in children ages 2-5 and in ages 6 months to 2 years is expected in the fourth quarter of this year. 

Next Up

mickey moore driver's license shared

Beleaguered Ward 9 city council candidate loses Strib endorsement

Mickey Moore has faced questions in recent days about where he actually lives.

CDC biohazard scientist health work

New clue may explain how rare tropical disease sickened Minnesotan

The disease, known as melioidosis, killed 2 people earlier this year.

Sen Mark Koran crop

MN lawmaker encourages donations for locals charged in Jan. 6 insurrection

"They are a good family!" Sen. Mark Koran wrote Friday.

money

Money Gal Coaching: Mastering the spiritual parts of money

Kelly Blodgett used her passion behind becoming debt free to launch Money Gal Coaching.

University of minnesota sign

U of M will now require proof that employees have been vaccinated for COVID

Previously, only students were required to be vaccinated.

Jim Hagedorn

Report reveals details about ethics investigation into Rep. Hagedorn

The congressman described the report's findings as "unfounded conclusions."

33462769592_d32f34fd48_k

SkyWest cancels hundreds of flights due to server error

More than 80 have been canceled at MSP Airport.

elk

First elk in more than 100 years spotted in parts of southern WI

The elk population was reintroduced to Wisconsin in recent decades.

grand marais

10 beautiful Minnesota cities to visit for outdoor adventures

These places are perfect for a day trip or a weekend getaway.

Related

Wikimedia Commons - COVID vaccine, pfizer, shot - Martin G

Pfizer to seek emergency use authorization to vaccinate kids ages 5 to 11

Pfizer says clinical trials have revealed positive results.

covid vaccine card

FDA gives full approval to Pfizer's COVID-19 vaccine

This approval is expected to lead to more vaccine mandates.

covid-19, vaccine

Reports: FDA expected to OK use of Pfizer vaccine on young teens

Pfizer found its vaccine is very effective for people ages 12-15.

vaccine, covid

Pfizer says its COVID vaccine is effective in 12-15 year olds

The companies are asking for emergency use authorization.

flu shot, vaccine

Pfizer seeks permission for emergency use of COVID-19 vaccine

The drug maker says its vaccine is 95% effective and ready to be deployed.

coronavirus, covid-19

Pfizer, BioNTech SE announce their COVID-19 vaccine is 90% effective

The companies are applying for FDA approval later in November.

Wikimedia Commons - COVID vaccine, pfizer, shot - Martin G

FDA grants emergency use of COVID-19 booster shot for immunocompromised

A booster shot would serve as a third dose of the Moderna or Pfizer-BioNTech vaccine.

Screen Shot 2021-03-03 at 2.01.04 PM

U.S. recommends pausing Johnson & Johnson vaccines to review rare blood clot

There have been six reports of blood clots of the 6.8 million vaccines given.